Gene · 1999
Papers2,176
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,176
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New insight into circRNAs: characterization, strategies, and biomedical applications. | Exp Hematol Oncol | 2023 | 37828589 | PubTator, text mining | PubMed |
| Long-term benefits of physical activity in adult patients with late onset Pompe disease: a retrospective cohort study with 10 years of follow-up. | Orphanet J Rare Dis | 2023 | 37821981 | PubTator, text mining | PubMed |
| Comparative genomic analysis reveals differential genomic characteristics and featured genes between rapid- and slow-growing non-tuberculous mycobacteria. | Front Microbiol | 2023 | 37808319 | PubTator, text mining | PubMed |
| Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+ T cell infiltration and functional transition. | J Immunother Cancer | 2023 | 37802603 | PubTator, text mining | PubMed |
| ESX1 gene as a potential candidate responsible for male infertility in nonobstructive azoospermia. | Sci Rep | 2023 | 37783880 | PubTator, text mining | PubMed |
| Loss of DDRGK1 impairs IRE1α UFMylation in spondyloepiphyseal dysplasia. | Int J Biol Sci | 2023 | 37781516 | PubTator, text mining | PubMed |
| Development and validation of prognostic index based on purine metabolism genes in patients with bladder cancer. | Front Med (Lausanne) | 2023 | 37780567 | PubTator, text mining | PubMed |
| Identification of Tumor Antigens and Immune Subtypes of High-grade Serous Ovarian Cancer for mRNA Vaccine Development. | J Cancer | 2023 | 37779866 | PubTator, text mining | PubMed |
| Mammal Reproductive Homeobox (Rhox) Genes: An Update of Their Involvement in Reproduction and Development. | Genes (Basel) | 2023 | 37761825 | PubTator, text mining | PubMed |
| Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies. | Cell Commun Signal | 2023 | 37723510 | PubTator, text mining | PubMed |
| microRNAs delivered by small extracellular vesicles in MSCs as an emerging tool for bone regeneration. | Front Bioeng Biotechnol | 2023 | 37720323 | PubTator, text mining | PubMed |
| Meta-analysis of integrated ChIP-seq and transcriptome data revealed genomic regions affected by estrogen receptor alpha in breast cancer. | BMC Med Genomics | 2023 | 37715225 | PubTator, text mining | PubMed |
| The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer. | Sci Rep | 2023 | 37714872 | PubTator, text mining | PubMed |
| Metformin-induced activation of Ca2+ signaling prevents immune infiltration/pathology in Sjogren's syndrome-prone mouse models. | J Transl Autoimmun | 2023 | 37711153 | PubTator, text mining | PubMed |
| KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer. | Adv Sci (Weinh) | 2023 | 37702443 | PubTator, text mining | PubMed |
| Deciphering a shared transcriptomic regulation and the relative contribution of each regulator type through endometrial gene expression signatures. | Reprod Biol Endocrinol | 2023 | 37700285 | PubTator, text mining | PubMed |
| Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary-pancreatic cancers. | J Gastroenterol | 2023 | 37698719 | PubTator, text mining | PubMed |
| The Case for the Target of Rapamycin Pathway as a Candidate Circadian Oscillator. | Int J Mol Sci | 2023 | 37686112 | PubTator, text mining | PubMed |
| The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy. | Commun Biol | 2023 | 37684337 | PubTator, text mining | PubMed |
| The synergistic effect of EMT regulators and m6A modification on prognosis-related immunological signatures for ovarian cancer. | Sci Rep | 2023 | 37684273 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1999/papers?page=13